Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin R Lynch

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 30, 2005
Synthesis, stability, and implications of phosphothioate agonists of sphingosine-1-phosphate receptorsFrank W Foss, Jeremy J Clemens, Michael D Davis, et al.
Kidney International|October 31, 2008
Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injurySang-Kyung Jo, Amandeep Bajwa, Hong Ye, et al.
Medchemcomm|December 20, 2011
Development of a phosphatase-resistant, L-tyrosine derived LPA1/LPA3 dual antagonistJames E East, Karen M Carter, Perry C Kennedy, et al.
Cancer Letters|January 10, 2009
S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumorMei-Hong Li, Teresa Sanchez, Harold Yamase, et al.
Biochemistry|October 22, 2003
The G protein-coupled receptor GPR4 suppresses ERK activation in a ligand-independent mannerMeryem Bektas, Larry S Barak, Puneet S Jolly, et al.
Journal of Medicinal Chemistry|February 3, 2015
Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitorsNeeraj N Patwardhan, Emily A Morris, Yugesh Kharel, et al.
Bioorganic & Medicinal Chemistry Letters|April 12, 2015
Structure-activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitorsMolly D Congdon, Elizabeth S Childress, Neeraj N Patwardhan, et al.
The Journal of Biological Chemistry|January 24, 2007
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptorMyat Lin Oo, Shobha Thangada, Ming-Tao Wu, et al.
Journal of Medicinal Chemistry|January 3, 2020
Discovery of a Small Side Cavity in Sphingosine Kinase 2 that Enhances Inhibitor Potency and SelectivityChristopher D Sibley, Emily A Morris, Yugesh Kharel, et al.
The Biochemical Journal|August 19, 2011
Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphateYugesh Kharel, Thomas P Mathews, Amanda M Gellett, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry Letters|August 30, 2005
Synthesis, stability, and implications of phosphothioate agonists of sphingosine-1-phosphate receptorsFrank W Foss, Jeremy J Clemens, Michael D Davis, et al.
Kidney International|October 31, 2008
Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injurySang-Kyung Jo, Amandeep Bajwa, Hong Ye, et al.
Medchemcomm|December 20, 2011
Development of a phosphatase-resistant, L-tyrosine derived LPA1/LPA3 dual antagonistJames E East, Karen M Carter, Perry C Kennedy, et al.
Cancer Letters|January 10, 2009
S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumorMei-Hong Li, Teresa Sanchez, Harold Yamase, et al.
Biochemistry|October 22, 2003
The G protein-coupled receptor GPR4 suppresses ERK activation in a ligand-independent mannerMeryem Bektas, Larry S Barak, Puneet S Jolly, et al.
Journal of Medicinal Chemistry|February 3, 2015
Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitorsNeeraj N Patwardhan, Emily A Morris, Yugesh Kharel, et al.
Bioorganic & Medicinal Chemistry Letters|April 12, 2015
Structure-activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitorsMolly D Congdon, Elizabeth S Childress, Neeraj N Patwardhan, et al.
The Journal of Biological Chemistry|January 24, 2007
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptorMyat Lin Oo, Shobha Thangada, Ming-Tao Wu, et al.
Journal of Medicinal Chemistry|January 3, 2020
Discovery of a Small Side Cavity in Sphingosine Kinase 2 that Enhances Inhibitor Potency and SelectivityChristopher D Sibley, Emily A Morris, Yugesh Kharel, et al.
The Biochemical Journal|August 19, 2011
Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphateYugesh Kharel, Thomas P Mathews, Amanda M Gellett, et al.
Pageof 10